Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00413673 · ClinicalTrials.gov registry record · NA
Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel
A NA study, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00413673 is a NA study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT00413673, a NA study, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objective of this study is to conduct a prospective clinical trial to evaluate the safety and efficacy fo the VISX Excimer Laser system for the treatment of naturally occurring low to moderate myopia, with or without low levels of astigmatism, in U.S. Army personnel.
Interventions
- PROCEDURE PRK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-08 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00413673
The ClinicalTrials.gov registry entry for NCT00413673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRK is the first listed.
NCT00413673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00413673 about?
NCT00413673 is a clinical study titled "Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel". The objective of this study is to conduct a prospective clinical trial to evaluate the safety and efficacy fo the VISX Excimer Laser system for the treatment of naturally occurring low to moderate myopia, with or without low levels of astigmatism, in U.S. Army personnel.
What is the current status of trial NCT00413673?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2001-08. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00413673?
The interventions under investigation include: PRK (PROCEDURE).
Who is sponsoring clinical trial NCT00413673?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.